@article{c039a89534b24b4aac73e96a19debf70,
title = "Reply Elimination of All Inducible Ventricular Tachycardias as the Endpoint for Ablation",
author = "Miki Yokokawa and Kim, {Hyungjin Myra} and Kazim Baser and William Stevenson and Koichi Nagashima and {Della Bella}, Paolo and Pasquale Vergara and Gerhard Hindricks and Arash Arya and Katja Zeppenfeld and {De Riva Silva}, Marta and Daoud, {Emile G.} and Sunil Kumar and Kuck, {Karl Heinz} and Roland Tilz and Shibu Mathew and Hamid Ghanbari and Rakesh Latchamsetty and Fred Morady and Frank Bogun",
note = "Funding Information: Please note: Dr. Bogun has received funding from the LeDucq Foundation. Dr. Stevenson is coholder of a patent for needle ablation that is consigned to Brigham and Women's Hospital. Dr. Tilz has received research grants from Hansen Medical and St. Jude Medical; has received travel grants from St. Jude Medical, Biosense Webster, and Daiichi-Sankyo; and has received lecture fees from St. Jude Medical, Biosense Webster, Biotronik, Topera, Pfizer, Bristol-Myers Squibb, Bayer, and Sanofi. Dr. Kuck has received relevant research grants, consultant fees, and honoraria from Biosense Webster, Stereotaxis, Medtronic, St. Jude Medical, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this paper. ",
year = "2015",
doi = "10.1016/j.jacc.2015.09.066",
language = "English",
volume = "66",
pages = "2576--2577",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
number = "22",
}
